山东大学学报 (医学版) ›› 2022, Vol. 60 ›› Issue (12): 82-87.doi: 10.6040/j.issn.1671-7554.0.2022.0680
• • 上一篇
董亚琳,巩武贤,胡锦卓,李亚妮,王锡明
DONG Yalin, GONG Wuxian, HU Jinzhuo, LI Yani, WANG Ximing
摘要: 目的 分析紧张部内陷袋胆脂瘤的高分辨率CT(HRCT)征象,为影像诊断提供依据。 方法 回顾性分析经临床及病理证实的36例(36耳)紧张部内陷袋胆脂瘤患者HRCT资料,采用多平面重组(MPR)技术重建标准轴位及冠状位图像,由2位主任医师对病变形态特点、累及部位、听小骨破坏情况、周围骨结构改变和乳突气化程度等影像征象进行分析。 结果 36例紧张部胆脂瘤均表现为起源于中后鼓室的软组织密度灶,其中6例呈局限团块状,15例呈团片状,15例呈弥漫团块状;病变累及中下鼓室36例,上鼓室21例,乳突腔9例,上鼓室前隐窝7例,鼓室窦28例,面神经隐窝25例;1例听小骨完整,6例锤骨头破坏,17例锤骨柄破坏,14例砧骨体破坏,35例砧骨长脚破坏,11例砧骨短脚破坏,23例镫骨头破坏,21例镫骨前后弓破坏,30例听小骨外移;2例水平半规管破坏,3例面神经管椎曲段破坏,17例面神经管水平段破坏,2例面神经管垂直段破坏,5例盾板明显破坏,13例盾板毛糙,18例盾板完整,5例鼓窦入口扩大,5例乳突腔边缘骨质硬化;乳突气化程度分级为0级17例,1级10例,2级9例,3级0例。 结论 紧张部内陷袋胆脂瘤HRCT特征为中后鼓室软组织密度灶伴听小骨外移及破坏,听小骨破坏以砧骨长脚与镫骨板上结构多见。
中图分类号:
[1] Yung M, Tono T, Olszewska E, et al. EAONO/JOS joint consensus statements on the definitions, classification and staging of middle ear cholesteatoma [J]. J Int Adv Otol, 2017, 13(1): 1-8. [2] Tono T, Sakagami M, Kojima H, et al. Staging and classification criteria for middle ear cholesteatoma proposed by the Japan Otological Society [J]. Auris Nasus Larynx, 2017, 44(2): 135-140. [3] Louw L. Acquired cholesteatoma pathogenesis: stepwise explanations [J]. J Laryngol Otol, 2010, 124(6): 587-593. [4] Urík M, Tedla M, Hurník P. Pathogenesis of retraction pocket of the tympanic membrane-a narrative review [J]. Medicina(Kaunas), 2021, 57(5): 425. doi:10.3390 /medicina57050425. [5] 孔维丽, 吴君昊, 郑虹. 中耳胆脂瘤发病机制与治疗[J]. 国际耳鼻咽喉头颈外科杂志, 2019, 43(6):334-339. KONG Weili, WU Junhao, ZHENG Hong. Pathogenesis and treatment of middle ear cholesteatoma [J]. Journal of Shandong University(Health Sciences), 2019,43(6): 334-339. [6] 刘凯, 牛学才, 程东风, 等. 早期获得性中耳小胆脂瘤的HRCT表现[J]. 中国中西医结合影像学杂志, 2009, 7(4):3. LIU Kai, NIU Xuecai, CHENG Dongfeng. HRCT findings of acquired small cholesteatoma in the middle ear of early stage [J]. Chinese Imaging Journal of Integrated Traditional and Western Medicine, 2009, 7(4): 3. [7] 韩宇, 张昌明, 凤亚妮, 等. 紧张部内陷袋性胆脂瘤的临床特点及手术疗效[J]. 听力学及言语疾病杂志, 2019, 27(5):514-518. HAN Yu, ZHANG Changming, FENG Yani. Clinical characteristics and surgical effects of acquired primary pars tensa cholesteatoma [J]. Journal of Audiology and Speech Pathology, 2019, 27(5): 514-518. [8] Matsuda K, Tono T, Kojima H, et al. Practicality analysis of the staging system proposed by the Japan Otological Society for acquired middle ear cholesteatoma: a multicenter study of 446 surgical cases in Japan [J]. Auris Nasus Larynx, 2018, 45(1): 45-50. [9] Gamaleldin OA, Elsebaie NA, Khalifa MH, et al. Assessment of mass effect sign at high-resolution computed tomography in prediction of cholesteatoma [J]. J Comput Assist Tomogr, 2019, 43(2): 288-293. [10] Hool SL, Beckmann S, Hakim A, et al. Variability of the retrotympanum and its association with mastoid pneumatization in cholesteatoma patients [J]. Eur Arch Otorhinolaryngol, 2022.doi:10.1007/s00405-022-07465-w. [11] Silva MNL, Selaimen FA, Huve FDC, et al. Endoscopic-assisted canal wall-up tympanomastoidectomy for reduction of residual cholesteatoma [J]. Int Arch Otorhinolaryngol, 2021, 26(2): e260-e264. [12] Volgger V, Lindeskog G, Krause E, et al. Identification of risk factors for residual cholesteatoma in children and adults: a retrospective study on 110 cases of revision surgery [J]. Braz J Otorhinolaryngol, 2018, 86(2): 201-208. [13] Selwyn D, Howard J, Cuddihy P. Pre-operative prediction of cholesteatomas from radiology: retrospective cohort study of 106 cases [J]. J Laryngol Otol, 2019, 133(6): 477-481. [14] 李必强, 王小铭, 黄显龙, 等. HRCT常规重建与后处理对CSOM及中耳胆脂瘤诊断价值[J]. 中华耳科学杂志, 2015, 13(2):304-308. LI Biqiang, WANG Xiaoming, HUANG Xianlong, et al. The diagnostic value of HRCT image reconstruction and post-processing technology in chronic suppurative otitis media and middle ear cholesteatoma [J]. Chinese Journal of Otology, 2015, 13(2): 304-308. [15] Chiao W, Chieffe D, Fina M. Endoscopic management of primary acquired cholesteatoma [J]. Otolaryngol Clin North Am, 2021, 54(1): 129-145. [16] Yu Y, See J, Ng JH, et al. Patterns of middle-ear cholesteatoma and implications for surgical approach [J]. J Laryngol Otol, 2020, 1-5. doi: 10.1017/S0022215120000109. [17] 王方园, 吴南, 杨仕明, 等. 耳内镜中耳外科手术体系的建立[J]. 中华耳科学杂志, 2021, 19(2):186-191. WANG Fangyuan, WU Nan, YANG Shiming, et al. The diagnostic value of HRCT image reconstruction and post-processing technology in chronic suppurative otitis media and middle ear cholesteatoma [J]. Chinese Journal of Otology, 2021, 19(2):186-191. [18] 孙建军, 刘阳. 中耳炎临床分类和手术分型指南(2012)解读[J]. 中华耳鼻咽喉头颈外科杂志, 2013(1):6-10. [19] Parab SR, Khan MM. Endoscopic management of tympanic membrane retraction pockets: a two handed technique with endoscope holder [J]. Indian J Otolaryngol Head Neck Surg, 2019, 71(4): 504-511. [20] Rutkowska J, Ozgirgin N, Olszewska E. Cholesteatoma definition and classification: a literature review [J]. J Int Adv Otol, 2017, 13(2): 266-271. [21] Shinnabe A, Yamamoto H, Hara M, et al. Differences in clinical characteristics of fallopian canal dehiscence associated with pars flaccida and pars tensa cholesteatomas [J]. Eur Arch Otorhinolaryngol, 2014, 271(8): 2171-2175. [22] Rosito LS, Netto LF, Teixeira AR, et al. Classification of cholesteatoma according to growth patterns [J]. JAMA Otolaryngol Head Neck Surg, 2016, 142(2): 168-172. [23] Yoshida S, Seki S, Sugiyama T, Kikuchi S, Yoshida N, Iino Y. Comparative study on adhesive otitis media and pars tensa cholesteatoma in children [J]. Auris Nasus Larynx. 2022, 49(5): 790-796. [24] Shinnabe A, Hara M, Hasegawa M, et al. Differences in middle ear ventilation disorders between pars flaccida and pars tensa cholesteatoma in sonotubometry and patterns of tympanic and mastoid pneumatization [J]. Otol Neurotol, 2012, 33(5): 765-768. |
[1] | 王红阳. 精准医疗时代的肿瘤生物标志物发展[J]. 山东大学学报 (医学版), 2018, 56(10): 1-2. |
[2] | 刘新农,展翰翔,胡三元,张光永, 王磊. 血清miR-146a在脓毒症早期诊断中的价值[J]. 山东大学学报(医学版), 2013, 51(9): 92-94. |
[3] | . 脑钠肽在急性心肌梗死早期诊断中的实验研究[J]. 山东大学学报(医学版), 2009, 47(9): 40-43. |
[4] | 侯香华,关广聚. 尿液蛋白质组学研究进展[J]. 山东大学学报(医学版), 2007, 45(2): 214-216. |
[5] | 丁元萍,李笃民,孙晓卫,邓基波,张寒冰,荣宝刚,丁寿玲 . HRCT多平面重组及最大密度投影对慢性化脓性中耳炎听骨链病变的术前评估[J]. 山东大学学报(医学版), 2006, 44(6): 630-633. |
|